Clinical Trials › NCT06463743
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Sponsored by State University of New York at Buffalo
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 30
Target enrollment
1
U.S. states
Sep 2025
Start date
Jun 2027
Expected completion
Interventions / Treatments
metforminPlacebo
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
New York1 site
Buffalo
Participating MS centers on MS Buddy (1)
Jacobs MS Center for Treatment and Research
Buffalo, NY
Buffalo, NY
MS centers in New York
Compare treatment centers near a trial site by center type, providers and trials.
View New York centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.